BILLS-116hr2700ih.pdf

May 29, 2019 Jkt 15 U.S.C. 45 2019 180-day 2003 42 U.S.C. 2020 31 days 30 days 15 U.S.C. 12(a 7 days more than 6 months 5-year 14, 2019 later than 30 days At least 30 months 120 days 180 days 1-year 42 U.S.C. 701(c)(3)(C 10 days 2009 20 days 14 days fiscal year 2020 10 years 2019 3-year 1112 6 9 year 1ST SESSION H. R. 2700 later than 6 years 2018

the ‘‘Lowering Prescription

2700 IH the United States the District of Columbia the United States Patent and Trade- Washington Georgia Arkansas the United States of America United States BB Texas Ohio

INDIANS

U.S.C. SEC REMS NDA the Federal Food, Drug ETASU Commission the Public Health Service Act Federal uct Food, Drug the Public Health Service the Federal Trade Commission Act the Federal Trade GENERAL.—If Food and Drugs the Federal Trade Commission the National Health Service Corps the United States Court Federal Food, Drug the Committee on Energy and Commerce Health Centers and Other Public Health THE HOUSE OF REPRESENTATIVES GME the Department of Justice the Federal Food Medicare Bringing Low-Cost Options and Competition While Other Public Health Federal Regulations Generic Drugs Sec the Patient Protection and Afford- Other Public Health Priorities Act State the Patient Protection and Affordable the Medicare Prescription Drug, Improvement the Food and Drug Administration Biologics Congress COMMUNITY HEALTH CENTERS SHIMKUS Generic Drugs House of Representa- the National Health Service Corps Social Security a)(4

OLSON GRIFFITH SCALISE KINZINGER GUTHRIE Clayton FLORES DUNCAN WALDEN LONG LATTA STIVERS MITCHELL MCKINLEY SION BUCSHON JOHNSON RODGERS COLLINS aa)(AA UPTON HURD BURGESS BROOKS MULLIN HUDSON GIANFORTE WALBERG SENSENBRENNER HILL CARTER BILIRAKIS

generic filer community health health centers low cost service corps national health exclusivity drug competition subsequent prescription drug sec extension applicant unlawful